This is a mechanism module, not a specific disease. Disorder entries reference individual nodes via conforms_to (e.g., "phototransduction_cascade_dysfunction#Failure of Photoreceptor Light-Response Generation or Timely Recovery"). Gene-class substitutions a conforming trigger node makes: cone-cascade loss of function (CNGA3, CNGB3, GNAT2, PDE6C, PDE6H) in achromatopsia; cone opsin loss (OPN1LW/OPN1MW locus) in blue cone monochromacy; rod-cascade loss or gain of function (RHO, GNAT1, PDE6B, GNB3, GUCY2D/GUCA1A) in the Riggs form of congenital stationary night blindness; and shutoff-arm loss of function (GRK1, SAG in Oguchi disease; RGS9, RGS9BP in bradyopsia).
SCOPE - what this module deliberately does NOT cover. The Schubert-Bornschein forms of congenital stationary night blindness (NYX, GRM6, TRPM1, GPR179, LRIT3, CACNA1F) are a defect of glutamatergic signal TRANSMISSION from an intact photoreceptor to the ON-bipolar cell, not of the phototransduction cascade inside the photoreceptor. Their ERG signature is the reciprocal one - a preserved a-wave with a selectively reduced b-wave - and they are a distinct mechanism that must not be wired to these nodes. A CSNB entry covering both forms should conform only for its Riggs arm. Likewise, this module models the SIGNALLING defect; regeneration of the 11-cis-retinal chromophore that the cascade consumes is the retinoid_visual_cycle_disruption module, and photoreceptor cell death downstream of chronic cGMP/Ca2+ toxicity is photoreceptor_degeneration. A disorder may conform to more than one of the three in parallel, and several do.
Which cascade lesions cross the branch from stationary dysfunction to progressive photoreceptor degeneration, and can that be predicted from the direction in which the lesion moves the outer-segment cGMP set point?
KNOWLEDGE GAP
cascade_lesion_stationary_versus_degenerative
Attached to:
cGMP and Calcium Overload Handoff to Photoreceptor Degeneration
The same gene can produce either outcome. GNAT1 variants have been reported in both autosomal dominant and autosomal recessive congenital stationary night blindness and in autosomal recessive rod-cone dystrophy, and CNGA3 and CNGB3 variants cause both stationary achromatopsia and progressive cone dystrophy. If the stationary-versus-degenerative split tracked cleanly with whether the lesion raises or lowers cGMP, prognosis would be predictable from genotype; the reported allelic overlap suggests it does not, and the determinants are unresolved. This matters directly for conformance, because it decides whether an entry should wire to this module alone or also to photoreceptor_degeneration.
Proposed experiments:
Genotype-stratified longitudinal outer-retinal imaging in cascade-gene cohorts
Phototransduction Cascade Component Defect
trigger
The initiating lesion is a variant in a gene encoding a component of the photoreceptor phototransduction cascade. The affected protein may sit on the activation limb - the visual pigment itself, the transducin alpha/beta subunits, the PDE6 catalytic or inhibitory gamma subunit, either subunit of the cyclic-nucleotide-gated channel, or retinal guanylate cyclase and its calcium-sensing GCAP regulators - or on the shutoff limb, which quenches the activated cascade. The lesion is expressed cell-autonomously in rods, in cones, or in both, and this determines which half of the clinical picture dominates.
Downstream
-
Loss of Outer-Segment cGMP and Calcium Set-Point Control
Show evidence (2 references)
"Pathogenic variants in six genes encoding proteins composing the cone phototransduction cascade (CNGA3, CNGB3, PDE6C, PDE6H, GNAT2) and of the unfolded protein response (ATF6) have been related to ACHM cases"
Establishes the cone arm of the trigger: achromatopsia is caused by variants in genes whose products compose the cone phototransduction cascade, i.e. the cascade itself is the shared lesion rather than any one protein.
"Riggs CSNB demonstrates selective rod photoreceptor dysfunction and occurs due to mutations in genes encoding proteins involved in rod phototransduction cascade"
Establishes the rod arm of the same trigger, and names the clinical subtype (Riggs) that isolates a photoreceptor-intrinsic cascade lesion from the bipolar-transmission forms excluded from this module.
Loss of Outer-Segment cGMP and Calcium Set-Point Control
amplifier
Phototransduction works by holding cGMP - and through the cGMP-gated conductance, Ca2+ - at a set point that light transiently lowers. The concentration is the running balance of synthesis by guanylate cyclase against hydrolysis by PDE6, with Ca2+ feeding back on the cyclase through GCAPs. A cascade lesion breaks that balance in a direction set by the gene: a null CNG channel or PDE6 activator leaves the conductance shut and Ca2+ chronically low; loss of PDE6 activity, or constitutive cyclase activation, leaves cGMP and Ca2+ chronically high; a shutoff-arm lesion leaves the hydrolytic arm running after the light is gone. This is the amplification step that converts a molecular defect into a cell-wide loss of signalling competence.
Downstream
-
Failure of Photoreceptor Light-Response Generation or Timely Recovery
Show evidence (2 references)
"cGMP metabolism in the signal-transducing photoreceptor outer segment reflects the balance of cGMP synthesis (catalyzed by guanylyl cyclase) and degradation (catalyzed by the photoreceptor phosphodiesterase, PDE6)."
States the synthesis-versus-hydrolysis balance that this node asserts is lost when a cascade component fails. Evidence source is OTHER because this is a structural and enzymological review.
"Cone photoreceptor cyclic nucleotide-gated (CNG) channels play an essential role in phototransduction and cellular Ca2+ homeostasis."
Links the cascade component to the calcium arm of the set point specifically, supporting the coupling this node asserts between the cGMP-gated conductance and outer-segment Ca2+.
Failure of Photoreceptor Light-Response Generation or Timely Recovery
central effector
The rate-limiting, disorder-agnostic node. Normal vision requires that a photon-triggered fall in cGMP close the outer-segment conductance and hyperpolarize the cell, and that the cascade then be quenched so the cell recovers its dark current and can respond again. A cascade lesion abolishes one or the other. Activation-arm defects mean the light response is never generated - the cell is electrically silent to light. Shutoff-arm defects mean the response is generated but not terminated, so the photoreceptor stays desensitized and dark adaptation takes hours rather than minutes; the dark-adapted state is eventually reached, which is why these patients are night-blind rather than blind. Every conforming disorder funnels through this node, and it is the module's key conformance target.
Downstream
-
Collapse of the Photoreceptor-Derived Electroretinogram Response
Show evidence (3 references)
"Upon light stimulation, rapid activation of PDE6 by the heterotrimeric G-protein (transducin) triggers a dramatic drop in cGMP levels that lead to cell hyperpolarization."
States the normal light-response generation step whose failure defines the activation arm of this node. Evidence source is OTHER because this is a review.
"Oguchi disease is a rare form of congenital stationary night blindness resulting from arrestin-1 (SAG) or rhodopsin kinase (GRK1) loss-of-function mutations."
Establishes the shutoff arm of this node as a distinct route to the same rate-limiting failure: the two Oguchi genes are the kinase and the arrestin that quench an activated cascade. Evidence source is OTHER because this is a literature review.
"Unlike other congenital nyctalopias, patients with Oguchi disease can reach the dark-adapted state, albeit only after several hours of sustained darkness exposure."
Substantiates the specific claim this node makes about the shutoff arm - recovery is delayed rather than abolished - which is what separates a quench defect from an activation defect clinically.
Collapse of the Photoreceptor-Derived Electroretinogram Response
effector
Because the a-wave of the full-field electroretinogram is the summed photoreceptor light response, a cascade lesion is directly readable as loss of the a-wave generated by the affected cell class, with the b-wave reduced secondarily because the bipolar cells downstream have nothing to be driven by. In the rod-cascade (Riggs) case the scotopic a-wave is lost and the b-wave is small; in the cone-cascade case the photopic and flicker responses are extinguished while scotopic responses are preserved. This is the module's objective effector-level readout and is what distinguishes a photoreceptor-intrinsic cascade defect from the reciprocal photoreceptor-to-bipolar transmission defect, where the a-wave is preserved and the b-wave is selectively lost.
Downstream
-
Congenital Non-Progressive Photoreceptor Dysfunction
-
cGMP and Calcium Overload Handoff to Photoreceptor Degeneration
Show evidence (2 references)
"Autosomal dominant congenital stationary night blindness (adCSNB) is rare and results from altered phototransduction giving a Riggs type of electroretinogram (ERG) with loss of the rod a-wave and small b-waves."
Directly ties altered phototransduction to the a-wave-dominant ERG signature this node asserts, including the secondary reduction of the b-wave.
"While the Riggs form represents a dysfunction of the rods, a signal transmission defect from photoreceptors to bipolar cell is described in patients with the more frequently occurring Schubert-Bornschein form."
Supports the discriminating claim in this node's description, and is the citation behind the module's scope note excluding the photoreceptor-to-bipolar transmission forms. Evidence source is OTHER because this is a review.
Congenital Non-Progressive Photoreceptor Dysfunction
consequence
The characteristic clinical outcome: visual dysfunction that is present from birth or early infancy and, in the pure signalling forms, remains essentially stationary over decades. Which symptoms dominate is set by which photoreceptor class carries the lesion. A rod-cascade defect gives night blindness with normal daytime acuity and a normal fundus. A cone-cascade defect gives poor visual acuity, nystagmus, photophobia and loss of colour discrimination in all axes, with preserved scotopic vision. Stationarity is the point of contrast with the degenerative retinopathies: the cell is silenced, not lost.
Show evidence (2 references)
"The condition presents at birth or early infancy with poor visual acuity, nystagmus, photophobia, and colour vision loss in all axes."
Supports the cone-cascade half of this consequence node, including its congenital onset. Evidence source is OTHER because this is a review.
"night blindness is the only symptom and eye examination is otherwise normal"
Supports the rod-cascade half: an isolated rod cascade lesion presents as night blindness alone with an unremarkable fundus, which is the stationarity claim this node makes.
cGMP and Calcium Overload Handoff to Photoreceptor Degeneration
consequence
A conditional branch, not an obligatory step. When the cascade lesion leaves cGMP and Ca2+ chronically elevated rather than merely abolishing the light response - loss of PDE6 hydrolytic activity being the archetype - the same second messengers that carry the signal become cytotoxic, and the disorder is a progressive retinal degeneration rather than a stationary dysfunction. Cone CNG channel deficiency reaches the same endpoint by a different route, through calcium dysregulation, ER stress and apoptosis. This node exists to mark the seam: the cell-death programme itself is modelled by the photoreceptor_degeneration module and is not re-derived here, and a disorder that crosses this branch should declare conformance to both modules.
Show evidence (2 references)
"photoreceptor death is preceded by abnormally high cGMP and Ca(2+) levels, likely because of continued synthesis of cGMP by guanylate cyclases and unregulated influx of Ca(2+) to toxic levels through CNG channels"
Establishes the conditional branch: in a PDE6-deficient model it is the chronically elevated cGMP and Ca2+ - the same messengers the cascade uses - that precede photoreceptor death, which is why only some cascade lesions degenerate.
"Cone death in CNG channel-deficient retinas involves endoplasmic reticulum (ER) stress-associated apoptosis, dysregulation of cellular/ER Ca2+ homeostasis, impaired protein folding/processing, and impaired ER-associated degradation (ERAD)."
Documents the second route across this branch - calcium dysregulation and ER stress in cone CNG channel deficiency - showing the handoff is not confined to the PDE6/cGMP archetype.
AAV-Mediated Phototransduction Gene Supplementation
Platform:
Gene therapy
Subretinal delivery of a functional copy of the mutated cascade gene by adeno-associated virus, aimed at restoring the missing component so the photoreceptor can generate or terminate a light response again. This is the module's canonical drug-target pattern and it targets the rate-limiting node directly. It is furthest advanced for the cone CNG channel subunits in achromatopsia, where several phase I/II trials are registered; it is a mechanism pattern here, not a treatment recommendation, and conforming disorders do not inherit it.
Evidence: 1